Hong-Xia Zhang1, Guo-Li Duan2, Chang-Nan Wang3, Yun-Qian Zhang3, Xiao-Yan Zhu4, Yu-Jian Liu5. 1. Department of Physiology, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China; Department of Respiration, Kongjiang Hospital, Shanghai 200093, China. 2. The Eight-year Program on Clinical Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, China. 3. Department of Physiology, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China. 4. Department of Physiology, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China. Electronic address: xiaoyanzhu@smmu.edu.cn. 5. Department of Pathophysiology, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, China. Electronic address: liuyujianz@yahoo.com.cn.
Abstract
BACKGROUND: Resveratrol, a natural plant polyphenol, has received increasing attention because its varied bioactivities, including the inhibition of tumorigenesis, lipid modification and calorie-restriction. We aimed to investigate the effect of resveratrol on oxidative/nitrative stress in endotoxemia-associated acute lung injury. METHODS: Mice were injected with lipopolysaccharide (LPS, 5 mg/kg, ip). Resveratrol at a dose of 0.3 mg/kg was administered alone or immediately before injection of LPS. Twenty four hours later, lung tissues were collected for histopathologic examination, and determination of malondialdehyde (MDA), H2O2, reduced/oxidized glutathione (GSH/GSSG) ratio, total antioxidant capacity (T-AOC), superoxide dismutase (SOD) activity, catalase (CAT) activity, inducible nitric oxide synthase (iNOS) expression, nitric oxide (NO) and peroxynitrite production. RESULTS: Resveratrol treatment improves histopathological changes in the lung during endotoxemia. Increased oxidative stress in endotoxemic lung was reversed by resveratrol treatment, as evidenced by the decreases of pro-oxidant biomarker (MDA and H2O2), and the increases of anti-oxidant biomarkers (GSH/GSSG ratio, T-AOC, CAT and SOD activity). Treatment with resveratrol inhibited endotoxemia-induced iNOS expression and NO production. Moreover, peroxynitrite formation in endotoxemic lung was significantly attenuated after resveratrol treatment. CONCLUSIONS: Resveratrol exerts protective effects against acute endotoxemia-associated lung injury. These beneficial effects may be due to both the anti-oxidant and anti-nitrative properties of resveratrol. These findings support the potential for resveratrol as a possible pharmacological agent to reduce acute lung injury resulting from oxidative/nitrative damage.
BACKGROUND:Resveratrol, a natural plant polyphenol, has received increasing attention because its varied bioactivities, including the inhibition of tumorigenesis, lipid modification and calorie-restriction. We aimed to investigate the effect of resveratrol on oxidative/nitrative stress in endotoxemia-associated acute lung injury. METHODS:Mice were injected with lipopolysaccharide (LPS, 5 mg/kg, ip). Resveratrol at a dose of 0.3 mg/kg was administered alone or immediately before injection of LPS. Twenty four hours later, lung tissues were collected for histopathologic examination, and determination of malondialdehyde (MDA), H2O2, reduced/oxidized glutathione (GSH/GSSG) ratio, total antioxidant capacity (T-AOC), superoxide dismutase (SOD) activity, catalase (CAT) activity, inducible nitric oxide synthase (iNOS) expression, nitric oxide (NO) and peroxynitrite production. RESULTS:Resveratrol treatment improves histopathological changes in the lung during endotoxemia. Increased oxidative stress in endotoxemic lung was reversed by resveratrol treatment, as evidenced by the decreases of pro-oxidant biomarker (MDA and H2O2), and the increases of anti-oxidant biomarkers (GSH/GSSG ratio, T-AOC, CAT and SOD activity). Treatment with resveratrol inhibited endotoxemia-induced iNOS expression and NO production. Moreover, peroxynitrite formation in endotoxemic lung was significantly attenuated after resveratrol treatment. CONCLUSIONS:Resveratrol exerts protective effects against acute endotoxemia-associated lung injury. These beneficial effects may be due to both the anti-oxidant and anti-nitrative properties of resveratrol. These findings support the potential for resveratrol as a possible pharmacological agent to reduce acute lung injury resulting from oxidative/nitrative damage.
Authors: Heather D Jones; Jeena Yoo; Timothy R Crother; Pierre Kyme; Anat Ben-Shlomo; Ramtin Khalafi; Ching W Tseng; William C Parks; Moshe Arditi; George Y Liu; Kenichi Shimada Journal: PLoS One Date: 2015-04-13 Impact factor: 3.240
Authors: Diego de Sá Coutinho; Maria Talita Pacheco; Rudimar Luiz Frozza; Andressa Bernardi Journal: Int J Mol Sci Date: 2018-06-20 Impact factor: 5.923
Authors: Maria Talita Pacheco de Oliveira; Diego de Sá Coutinho; Sílvia Stanisçuaski Guterres; Adriana Raffin Pohlmann; Patrícia Machado Rodrigues E Silva; Marco Aurélio Martins; Andressa Bernardi Journal: Pharmaceutics Date: 2021-05-10 Impact factor: 6.321